Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ludwig-Maximilians - University of Munich
Age
55–95
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patients aged ≥ 55 years, fulfilling criteria of the National Institute of Neurological and Communicative Disease and Stroke (NINCDS) and the Alzheimer's Disease and Related Disorders Association (ADRDA) for the diagnosis of clinically probable AD or Petersen's criteria of mild cognitive impairment (MCI)
No evidence for other psychiatric axis I disorders according to DSM-IV criteria
No uncontrolled arterial hypertension or diabetes mellitus
No history of drug/alcohol abuse
Cholinesterase inhibitors or Memantine must have been in a stabile doses at least 2 moths in AD subject group prior to the Baseline
The patient is able to provide written informed consent to participate in the study. If, at investigator's discretion, a patient is considered not to be capable to give legal consent, then written consent must also be obtained from the patient's legally acceptable representative.
You may not be if
Evidence for other psychiatric axis I disorders according to DSM-IV criteria
Uncontrolled arterial hypertension or diabetes mellitus
History of drug/alcohol abuse
No ability to participate and no willing to give informed consent and comply with the study restrictions
